Clinical Trials Directory

Trials / Conditions / Arterial Occlusive Diseases

Arterial Occlusive Diseases

90 registered clinical trials studyying Arterial Occlusive Diseases5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingSafety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With C
NCT07258290
TeleflexN/A
RecruitingSingle vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB
NCT06535568
Fondazione Ricerca e Innovazione Cardiovascolare ETSN/A
RecruitingA Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in
NCT07286578
Fundación EPICN/A
RecruitingResults of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemi
NCT05930145
Fundación EPICN/A
CompletedFLEX FIRST Registry Research Protocol
NCT05616104
VentureMed Group Inc.
UnknownPreliminary Tissue Monitoring During Endovascular Intervention Study
NCT04956523
Pedra Technology, PTE LTD
UnknownTissue Monitoring During Endovascular Intervention
NCT04744870
Pedra Technology, PTE LTD
UnknownPrimary FIbrinolysis and Secondary STenting Versus immEdiate Stenting in ST-segment Elevation Myocardial Infar
NCT04663932
Harbin Medical UniversityN/A
UnknownOptimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery St
NCT04666584
Odense University HospitalN/A
CompletedClinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusiv
NCT06046196
Yuhan CorporationPhase 4
CompletedDual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
NCT04624854
Harbin Medical UniversityPhase 4
Active Not RecruitingMultivessel TALENT
NCT04390672
National University of Ireland, Galway, IrelandN/A
CompletedAmmonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Amm
NCT04343209
Ionetix Corporation
UnknownSafety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coro
NCT04142021
National University of Ireland, Galway, Ireland
CompletedRegistry of Coronary Lithotripsy in Spain.
NCT04298307
Fundación EPIC
UnknownPROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Is
NCT03970538
LimFlow, Inc.N/A
UnknownLegDeb2 Global Registry for Use of Legflow in Peripheral Arteries
NCT04175197
Federico II University
CompletedThe Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD
NCT04089943
University of West FloridaN/A
UnknownIntracranial Stenting in Non-acute Symptomatic Ischemic Stroke
NCT05063630
Can Tho Stroke International Services HospitalN/A
CompletedDistributed Registry
NCT03898570
Stanford University
RecruitingSpectroscopy in Functional Assessment of Peripheral Artery Disease (spectroAMI)
NCT03723473
Centre Hospitalier Universitaire de Saint Etienne
CompletedCrossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3
NCT03724279
Taryag Medical Ltd.N/A
CompletedTelephone Health Coaching and Remote Exercise Monitoring for Peripheral Artery Disease
NCT03496948
Universitätsklinikum Hamburg-EppendorfN/A
CompletedReal World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon
NCT03193619
C. R. Bard
CompletedThe Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
NCT03856606
University of Texas at AustinN/A
CompletedProspective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 20
NCT03253692
National Heart, Lung, and Blood Institute (NHLBI)
CompletedFunctional Diagnostic Accuracy of Quantitative Flow Ratio in Tandem Lesions and Virtual Stenting
NCT03405506
Pulse Medical Imaging Technology (Shanghai) Co., Ltd
CompletedThe FAVOR II China Study
NCT03191708
China National Center for Cardiovascular Diseases
CompletedA Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries
NCT03037411
Boston Scientific Corporation
CompletedTrial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal A
NCT02921230
Boston Scientific CorporationN/A
UnknownIschemic Pain Control With Analgesic Methods Clinical Trial
NCT02841488
University of Sao Paulo General HospitalPhase 3
UnknownA Prospective Study: the Value of Using iFlow and PBV in the Endovascular Treatment of Infrapopliteal Arterial
NCT03248323
Peking Union Medical College Hospital
TerminatedIRIS-BVS AMI Registry
NCT02699671
Duk-Woo Park, MD
CompletedSafety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
NCT02561000
Tufts Medical CenterPhase 2
UnknownLate Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI
NCT02770651
Keimyung University Dongsan Medical Center
TerminatedEvaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice
NCT02622100
Duk-Woo Park, MD
Active Not RecruitingIRIS-Onyx Cohort in the IRIS-DES Registry
NCT02593994
Seung-Jung Park
CompletedThe Transfusion Triggers in Vascular Surgery Trial
NCT02465125
Naestved HospitalPhase 2
CompletedSafety/Tolerability and Pharmacokinetic Study of SID142
NCT02625714
SK Chemicals Co., Ltd.Phase 1
TerminatedThe ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study
NCT02793349
The University of New South WalesN/A
CompletedReal-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
NCT02424383
C. R. BardN/A
CompletedThe COPPER-B Trial
NCT02395744
Horizons International Peripheral GroupN/A
CompletedDrug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery
NCT02212470
Instituto Dante Pazzanese de CardiologiaPhase 4
WithdrawnTelerobotic Ultrasound for Carotid Imaging - Feasibility Study
NCT05654935
Rush University Medical Center
CompletedEXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions.
NCT02057978
JW Medical Systems Ltd
CompletedClinical Benefits of B-Flow Ultrasound
NCT02008097
University of WashingtonN/A
UnknownThe ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary Lesions
NCT01915420
Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.
CompletedPost-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
NCT01917682
Corindus Inc.
CompletedNeurological Complications Comparing Endoscopically vs. Open Harvest of the Radial Artery
NCT01848886
Rigshospitalet, DenmarkN/A
CompletedABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold
NCT01583608
Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.
TerminatedThe eSVS® Mesh Post-Marketing Trial
NCT01520311
Kips Bay Medical, Inc.N/A
TerminatedThe eSVS® Mesh Randomized Post-Market Study
NCT01462721
Kips Bay Medical, Inc.N/A
CompletedGORE Flow Reversal System and GORE Embolic Filter Extension Study
NCT01343667
W.L.Gore & AssociatesN/A
CompletedEvaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (P
NCT01275092
Corindus Inc.Phase 2
UnknownThe Use of Cardiovascular Biomarkers in Abdominal Aortic Surgery
NCT02122497
Prim PD Dr Afshin Assadian
CompletedRESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small D
NCT01150500
Medtronic VascularN/A
UnknownComparison of Stent and Prothesis Bypass in Superficial Femoral Artery
NCT01147419
Peking Union Medical College HospitalPhase 4
CompletedCombined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomogr
NCT00934037
Johns Hopkins UniversityPhase 3
CompletedRESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent
NCT00927940
Medtronic VascularN/A
CompletedFeasability Study of Autologous Bone Marrow Aspirate Concentrate for Treatment of CLI
NCT00595257
Harvest TechnologiesPhase 1 / Phase 2
CompletedA Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft O
NCT00418483
Grifols Therapeutics LLCPhase 1
CompletedIntra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)
NCT00371371
UMC UtrechtPhase 1 / Phase 2
TerminatedStudy of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery
NCT00338585
ARCA Biopharma, Inc.Phase 3
CompletedYUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study
NCT00664963
Herz-Zentrums Bad KrozingenPhase 4
TerminatedThe Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions.
NCT00289055
Cordis US Corp.Phase 4
CompletedSafety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arteri
NCT00282646
Johann Wolfgang Goethe University HospitalPhase 2
CompletedThe Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent
NCT00235131
Cordis US Corp.Phase 4
CompletedStudy of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg A
NCT00115999
ARCA Biopharma, Inc.Phase 3
TerminatedIntra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion
NCT00123292
ThromboGenicsPhase 2
CompletedThe Study to Treat Superficial Femoral Artery Occlusions.
NCT00232843
Cordis US Corp.Phase 4
CompletedA Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodia
NCT00209443
GE HealthcarePhase 3
CompletedCASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease
NCT00174759
SanofiPhase 3
UnknownThunder Trial - Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries
NCT00156624
University Hospital TuebingenPhase 2 / Phase 3
CompletedHigh Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty
NCT00154050
Technische Universität DresdenN/A
CompletedThe ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery L
NCT00614848
Medtronic VascularN/A
CompletedAlfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
NCT00073554
ARCA Biopharma, Inc.Phase 2
CompletedBest Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral Artery Occlusions
NCT05503212
Centre Hospitalier Universitaire Vaudois
TerminatedSIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Ou
NCT00111826
VasogenPhase 3
CompletedMechanisms of Disability in Peripheral Arterial Disease
NCT00046592
National Heart, Lung, and Blood Institute (NHLBI)
UnknownRio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Periphera
NCT00156611
University Hospital TuebingenPhase 2 / Phase 3
CompletedPrevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
NCT00041925
Anesiva, Inc.Phase 2 / Phase 3
CompletedBlood Factors and Peripheral Arterial Disease Outcomes
NCT00035776
National Heart, Lung, and Blood Institute (NHLBI)
CompletedPlasma Transfusion in Major Vascular Surgery
NCT04514575
Naestved Hospital
CompletedPotential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
NCT00001531
National Heart, Lung, and Blood Institute (NHLBI)
CompletedDacron vs Dardik for Fem-Pop Bypass
NCT00523263
Radboud University Medical CenterPhase 3
CompletedArterial Disease Multifactorial Intervention Trial (ADMIT)
NCT00000539
National Heart, Lung, and Blood Institute (NHLBI)Phase 3
CompletedNatural History of Peripheral Arterial Disease
NCT00005254
National Heart, Lung, and Blood Institute (NHLBI)
CompletedCholesterol-Lowering Atherosclerosis Study (CLAS)
NCT00000599
National Heart, Lung, and Blood Institute (NHLBI)Phase 3
CompletedEtiology and Prevalence of Peripheral Arterial Disease
NCT00005142
National Heart, Lung, and Blood Institute (NHLBI)
CompletedFramingham Heart Study
NCT00005121
National Heart, Lung, and Blood Institute (NHLBI)